A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

On Wednesday, drugmaker Eli Lilly announced positive results from a large, phase-3 clinical trial, testing Zepbound (a drug .

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the ...

Eli Lilly on Thursday reported promising results for a daily pill that could serve as an alternative to injectable ...

Like them, these weight-loss drugs have the potential to reshape the way we think of what it means to be sick and what it takes to be healthy.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...